Washington (AFP) - US regulators Friday banned the sale and import of small cigarettes known as bidis made by an Indian company, their first such action since being given oversight of tobacco products in 2009.
Bidis are small, hand-rolled cigarettes that contain tobacco wrapped in leaves from a tendu tree, and may come in various flavors.
The move by the US Food and Drug Administration applies to four varieties made by Jash International, which an agency spokeswoman described to AFP as an Indian company with headquarters in Illinois.
The ban came about because the products were found to be substantially different from existing tobacco products on the market as of 2007, and did not meet new regulatory requirements, the FDA said.
"This means they can no longer be sold or distributed in interstate commerce or imported into the United States," the FDA said in a statement.
The order applies to Sutra Bidis Red, Sutra Bidis Menthol, Sutra Bidis Red Cone, and Sutra Bidis Menthol Cone.
Existing inventory may be subject to seizure without further notice, the FDA said.
"Companies that continue to sell and distribute these products in the United States may be subject to enforcement actions by the FDA."
Jash International did not immediately respond to an AFP request for comment.
The Centers for Disease Control and Prevention has warned that bidis contain higher levels of nicotine, tar and carbon monoxide than conventional cigarettes.
"Smoke from a bidi contains three to five times the amount of nicotine as a regular cigarette and places users at risk for nicotine addiction," said the CDC website.
Two percent of high school students and 1.7 percent of middle school students smoke bidis, according to a 2011 CDC survey.
The FDA was granted authority to regulate tobacco products in 2009 as a result of the Tobacco Control Act, signed into law by President Barack Obama.
The law is aimed particularly at curbing smoking among young people.
"Historically, tobacco companies controlled which products came on and off the market without any oversight," said Mitch Zeller, director of the FDA's Center for Tobacco Products.
"But the Tobacco Control Act gave the FDA, a science-based regulatory agency, the authority to review applications and determine which new tobacco products may be sold and distributed under the law in order to protect public health."